Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783254352> ?p ?o ?g. }
- W2783254352 endingPage "2864" @default.
- W2783254352 startingPage "2850" @default.
- W2783254352 abstract "The peptide hormone prolactin (PRL) and certain members of the epidermal growth factor (EGF) family play central roles in mammary gland development and physiology, and their dysregulation has been implicated in mammary tumorigenesis. Our recent studies have revealed that the CUB and zona pellucida-like domain-containing protein 1 (CUZD1) is a critical factor for PRL-mediated activation of the transcription factor STAT5 in mouse mammary epithelium. Of note, CUZD1 controls production of a specific subset of the EGF family growth factors and consequent activation of their receptors. Here, we found that consistent with this finding, CUZD1 overexpression in non-transformed mammary epithelial HC11 cells increases their proliferation and induces tumorigenic characteristics in these cells. When introduced orthotopically in mouse mammary glands, these cells formed adenocarcinomas, exhibiting elevated levels of STAT5 phosphorylation and activation of the EGF signaling pathway. Selective blockade of STAT5 phosphorylation by pimozide, a small-molecule inhibitor, markedly reduced the production of the EGF family growth factors and inhibited PRL-induced tumor cell proliferation in vitro. Pimozide administration to mice also suppressed CUZD1-driven mammary tumorigenesis in vivo. Analysis of human MCF7 breast cancer cells indicated that CUZD1 controls the production of the same subset of EGF family members in these cells as in the mouse. Moreover, pimozide treatment reduced the proliferation of these cancer cells. Collectively, these findings indicate that overexpression of CUZD1, a regulator of growth factor pathways controlled by PRL and STAT5, promotes mammary tumorigenesis. Blockade of the STAT5 signaling pathway downstream of CUZD1 may offer a therapeutic strategy for managing these breast tumors. The peptide hormone prolactin (PRL) and certain members of the epidermal growth factor (EGF) family play central roles in mammary gland development and physiology, and their dysregulation has been implicated in mammary tumorigenesis. Our recent studies have revealed that the CUB and zona pellucida-like domain-containing protein 1 (CUZD1) is a critical factor for PRL-mediated activation of the transcription factor STAT5 in mouse mammary epithelium. Of note, CUZD1 controls production of a specific subset of the EGF family growth factors and consequent activation of their receptors. Here, we found that consistent with this finding, CUZD1 overexpression in non-transformed mammary epithelial HC11 cells increases their proliferation and induces tumorigenic characteristics in these cells. When introduced orthotopically in mouse mammary glands, these cells formed adenocarcinomas, exhibiting elevated levels of STAT5 phosphorylation and activation of the EGF signaling pathway. Selective blockade of STAT5 phosphorylation by pimozide, a small-molecule inhibitor, markedly reduced the production of the EGF family growth factors and inhibited PRL-induced tumor cell proliferation in vitro. Pimozide administration to mice also suppressed CUZD1-driven mammary tumorigenesis in vivo. Analysis of human MCF7 breast cancer cells indicated that CUZD1 controls the production of the same subset of EGF family members in these cells as in the mouse. Moreover, pimozide treatment reduced the proliferation of these cancer cells. Collectively, these findings indicate that overexpression of CUZD1, a regulator of growth factor pathways controlled by PRL and STAT5, promotes mammary tumorigenesis. Blockade of the STAT5 signaling pathway downstream of CUZD1 may offer a therapeutic strategy for managing these breast tumors." @default.
- W2783254352 created "2018-01-26" @default.
- W2783254352 creator A5015120563 @default.
- W2783254352 creator A5022400005 @default.
- W2783254352 creator A5046032162 @default.
- W2783254352 creator A5076507508 @default.
- W2783254352 creator A5076550878 @default.
- W2783254352 creator A5084556730 @default.
- W2783254352 creator A5089055801 @default.
- W2783254352 date "2018-02-01" @default.
- W2783254352 modified "2023-09-30" @default.
- W2783254352 title "Aberrantly high expression of the CUB and zona pellucida-like domain-containing protein 1 (CUZD1) in mammary epithelium leads to breast tumorigenesis" @default.
- W2783254352 cites W1268960040 @default.
- W2783254352 cites W1488950205 @default.
- W2783254352 cites W1539181678 @default.
- W2783254352 cites W1764386416 @default.
- W2783254352 cites W1833542149 @default.
- W2783254352 cites W1893919883 @default.
- W2783254352 cites W1964321121 @default.
- W2783254352 cites W1964492318 @default.
- W2783254352 cites W1965300615 @default.
- W2783254352 cites W1974024530 @default.
- W2783254352 cites W1977341142 @default.
- W2783254352 cites W1981348906 @default.
- W2783254352 cites W1987259882 @default.
- W2783254352 cites W1988055795 @default.
- W2783254352 cites W1994231910 @default.
- W2783254352 cites W1995242599 @default.
- W2783254352 cites W1997387647 @default.
- W2783254352 cites W1997785224 @default.
- W2783254352 cites W2002536557 @default.
- W2783254352 cites W2004688321 @default.
- W2783254352 cites W2008995921 @default.
- W2783254352 cites W2010571055 @default.
- W2783254352 cites W2013733324 @default.
- W2783254352 cites W2013748221 @default.
- W2783254352 cites W2014254693 @default.
- W2783254352 cites W2015492787 @default.
- W2783254352 cites W2016941990 @default.
- W2783254352 cites W2022819740 @default.
- W2783254352 cites W2023278718 @default.
- W2783254352 cites W2023523424 @default.
- W2783254352 cites W2024420354 @default.
- W2783254352 cites W2027804163 @default.
- W2783254352 cites W2032196335 @default.
- W2783254352 cites W2034072513 @default.
- W2783254352 cites W2044186696 @default.
- W2783254352 cites W2045990264 @default.
- W2783254352 cites W2047457300 @default.
- W2783254352 cites W2051577500 @default.
- W2783254352 cites W2052824079 @default.
- W2783254352 cites W2054946394 @default.
- W2783254352 cites W2056295130 @default.
- W2783254352 cites W2058705034 @default.
- W2783254352 cites W2059048157 @default.
- W2783254352 cites W2064047613 @default.
- W2783254352 cites W2070570544 @default.
- W2783254352 cites W2079648398 @default.
- W2783254352 cites W2081202387 @default.
- W2783254352 cites W2083254800 @default.
- W2783254352 cites W2087187453 @default.
- W2783254352 cites W2091005988 @default.
- W2783254352 cites W2093953283 @default.
- W2783254352 cites W2096638827 @default.
- W2783254352 cites W2096939566 @default.
- W2783254352 cites W2097542484 @default.
- W2783254352 cites W2100183121 @default.
- W2783254352 cites W2100763819 @default.
- W2783254352 cites W2100823111 @default.
- W2783254352 cites W2114843025 @default.
- W2783254352 cites W2116282893 @default.
- W2783254352 cites W2117468155 @default.
- W2783254352 cites W2120779205 @default.
- W2783254352 cites W2122615310 @default.
- W2783254352 cites W2122855814 @default.
- W2783254352 cites W2123882674 @default.
- W2783254352 cites W2127176880 @default.
- W2783254352 cites W2128985829 @default.
- W2783254352 cites W2130473078 @default.
- W2783254352 cites W2147028876 @default.
- W2783254352 cites W2147505029 @default.
- W2783254352 cites W2149441684 @default.
- W2783254352 cites W2153587517 @default.
- W2783254352 cites W2155336881 @default.
- W2783254352 cites W2156668084 @default.
- W2783254352 cites W2160045991 @default.
- W2783254352 cites W2164350387 @default.
- W2783254352 cites W2169141341 @default.
- W2783254352 cites W2173741999 @default.
- W2783254352 cites W2324295263 @default.
- W2783254352 cites W2341074398 @default.
- W2783254352 cites W2593891860 @default.
- W2783254352 cites W63627267 @default.
- W2783254352 doi "https://doi.org/10.1074/jbc.ra117.000162" @default.
- W2783254352 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5827451" @default.
- W2783254352 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29321207" @default.
- W2783254352 hasPublicationYear "2018" @default.
- W2783254352 type Work @default.